Balchem Corporation Revenue
Balchem Corporation (BCPC) reported Revenue of $284.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-31
- Balchem Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $284.00M, a 11.17% increase year-over-year.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $270.71M, a 8.06% increase year-over-year.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $263.62M, a 9.84% increase year-over-year.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $267.56M, a 11.51% increase year-over-year.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.04B, a 8.75% increase from fiscal 2024.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for fiscal 2024 was $953.68M, a 3.39% increase from fiscal 2023.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for fiscal 2023 was $922.44M, a 2.11% decline from fiscal 2022.
- Balchem Corporation revenue from contract with customer, excluding assessed tax for fiscal 2022 was $942.36M, a 17.94% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $284.00M 10-Q · filed 2026-07-31 | $554.71M 10-Q · filed 2026-07-31 | $818.32M derived: sum of 3 quarters · filed 2026-07-31 | $1.09B derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $270.71M 10-Q · filed 2026-04-30 | $534.33M derived: sum of 2 quarters · filed 2026-04-30 | $801.88M derived: sum of 3 quarters · filed 2026-04-30 | $1.06B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $263.62M 10-K · filed 2026-02-20 | $531.17M derived: sum of 2 quarters · filed 2026-02-20 | $786.64M derived: sum of 3 quarters · filed 2026-07-31 | $1.04B 10-K · filed 2026-02-20 |
| 2025-09-30 | $267.56M 10-K · filed 2026-02-20 | $523.02M derived: sum of 2 quarters · filed 2026-07-31 | $773.54M 10-Q · filed 2025-10-21 | $1.01B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $255.47M 10-Q · filed 2026-07-31 | $505.99M 10-Q · filed 2026-07-31 | $745.99M derived: sum of 3 quarters · filed 2026-07-31 | $985.93M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $250.52M 10-Q · filed 2026-04-30 | $490.52M derived: sum of 2 quarters · filed 2026-04-30 | $730.46M derived: sum of 3 quarters · filed 2026-04-30 | $964.54M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $240.00M 10-K · filed 2026-02-20 | $479.94M derived: sum of 2 quarters · filed 2026-02-20 | $714.02M derived: sum of 3 quarters · filed 2026-02-20 | $953.68M 10-K · filed 2026-02-20 |
| 2024-09-30 | $239.94M 10-K · filed 2026-02-20 | $474.02M derived: sum of 2 quarters · filed 2026-02-20 | $713.68M 10-Q · filed 2025-10-21 | $942.38M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $234.08M 10-K · filed 2026-02-20 | $473.74M 10-Q · filed 2025-07-31 | $702.44M derived: sum of 3 quarters · filed 2026-02-20 | $932.39M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $239.66M 10-K · filed 2026-02-20 | $468.36M derived: sum of 2 quarters · filed 2026-02-20 | $698.31M derived: sum of 3 quarters · filed 2026-02-20 | $929.56M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $228.70M 10-K · filed 2025-02-21 | $458.65M derived: sum of 2 quarters · filed 2025-02-21 | $689.90M derived: sum of 3 quarters · filed 2025-02-21 | $922.44M 10-K · filed 2026-02-20 |
| 2023-09-30 | $229.95M 10-K · filed 2025-02-21 | $461.20M derived: sum of 2 quarters · filed 2025-02-21 | $693.74M 10-Q · filed 2024-10-25 | $926.27M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $231.25M 10-K · filed 2025-02-21 | $463.79M 10-Q · filed 2024-07-26 | $696.32M derived: sum of 3 quarters · filed 2025-02-21 | $940.59M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $232.54M 10-K · filed 2025-02-21 | $465.07M derived: sum of 2 quarters · filed 2025-02-21 | $709.34M derived: sum of 3 quarters · filed 2025-02-21 | $946.03M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $232.53M 10-K · filed 2024-02-16 | $476.80M derived: sum of 2 quarters · filed 2024-02-16 | $713.49M derived: sum of 3 quarters · filed 2024-02-16 | $942.36M 10-K · filed 2025-02-21 |
| 2022-09-30 | $244.27M 10-K · filed 2024-02-16 | $480.96M derived: sum of 2 quarters · filed 2024-02-16 | $709.83M 10-Q · filed 2023-10-27 | $922.96M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $236.69M 10-K · filed 2024-02-16 | $465.56M 10-Q · filed 2023-07-28 | $678.69M derived: sum of 3 quarters · filed 2024-02-16 | $876.56M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $228.87M 10-K · filed 2024-02-16 | $442.00M derived: sum of 2 quarters · filed 2024-02-16 | $639.87M derived: sum of 3 quarters · filed 2024-02-16 | $842.23M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $213.13M 10-K · filed 2023-02-24 | $411.00M derived: sum of 2 quarters · filed 2023-02-24 | $613.37M derived: sum of 3 quarters · filed 2023-02-24 | $799.02M 10-K · filed 2024-02-16 |
| 2021-09-30 | $197.87M 10-K · filed 2023-02-24 | $400.23M derived: sum of 2 quarters · filed 2023-02-24 | $585.89M 10-Q · filed 2022-11-04 | $766.60M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $202.37M 10-K · filed 2023-02-24 | $388.02M 10-Q · filed 2022-07-29 | $568.73M derived: sum of 3 quarters · filed 2023-02-24 | $743.87M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $185.66M 10-K · filed 2023-02-24 | $366.37M derived: sum of 2 quarters · filed 2023-02-24 | $541.51M derived: sum of 3 quarters · filed 2023-02-24 | $714.86M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $180.71M 10-K · filed 2022-02-24 | $355.85M derived: sum of 2 quarters · filed 2022-02-24 | $529.21M derived: sum of 3 quarters · filed 2022-02-24 | $703.64M 10-K · filed 2023-02-24 |
| 2020-09-30 | $175.14M 10-K · filed 2022-02-24 | $348.50M derived: sum of 2 quarters · filed 2022-02-24 | $522.93M 10-Q · filed 2021-10-29 | $689.46M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $173.35M 10-K · filed 2022-02-24 | $347.79M 10-Q · filed 2021-07-30 | $514.32M derived: sum of 3 quarters · filed 2022-02-24 | $672.91M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $174.44M 10-K · filed 2022-02-24 | $340.96M derived: sum of 2 quarters · filed 2022-02-24 | $499.56M derived: sum of 3 quarters · filed 2022-02-24 | $661.11M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $166.53M 10-K · filed 2021-02-19 | $325.12M derived: sum of 2 quarters · filed 2021-02-19 | $486.68M derived: sum of 3 quarters · filed 2021-02-19 | $643.71M 10-K · filed 2022-02-24 |
| 2019-09-30 | $158.59M 10-K · filed 2021-02-19 | $320.15M derived: sum of 2 quarters · filed 2021-02-19 | $477.18M 10-Q · filed 2020-10-28 | $640.72M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $161.55M 10-K · filed 2021-02-19 | $318.58M 10-Q · filed 2020-07-31 | $482.12M derived: sum of 3 quarters · filed 2021-02-19 | $637.16M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $157.03M 10-K · filed 2021-02-19 | $320.57M derived: sum of 2 quarters · filed 2021-02-19 | $475.61M derived: sum of 3 quarters · filed 2021-02-19 | $639.30M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $163.54M 10-K · filed 2020-02-21 | $318.58M derived: sum of 2 quarters · filed 2020-02-21 | $482.27M derived: sum of 3 quarters · filed 2020-02-21 | $643.68M 10-K · filed 2021-02-19 |
| 2018-09-30 | $155.04M 10-K · filed 2020-02-21 | $318.73M derived: sum of 2 quarters · filed 2020-02-21 | $480.14M 10-Q · filed 2019-11-05 | $639.40M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $163.69M 10-K · filed 2020-02-21 | $325.10M 10-Q · filed 2019-08-01 | $484.36M derived: sum of 3 quarters · filed 2020-02-21 | $635.08M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $161.41M 10-K · filed 2020-02-21 | $320.67M derived: sum of 2 quarters · filed 2020-02-21 | $471.39M derived: sum of 3 quarters · filed 2020-02-21 | $618.47M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $159.26M 10-K · filed 2019-02-28 | $309.98M derived: sum of 2 quarters · filed 2019-02-28 | $457.06M derived: sum of 3 quarters · filed 2019-02-28 | $594.79M 10-K · filed 2020-02-21 |
| 2017-09-30 | $150.72M 10-K · filed 2019-02-28 | $297.80M derived: sum of 2 quarters · filed 2019-02-28 | $435.53M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $147.08M 10-K · filed 2019-02-28 | $284.81M 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $137.73M 10-K · filed 2019-02-28 | |||
| 2016-12-31 | $553.20M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Solstice Advanced Materials Inc. (SOLS) | United States | $8.905B | 67.02 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |